The two-dose Ad26.ZEBOV and MVA-BN-Filo vaccine regimen (Zabdeno and Mvabea) is recommended for preventive use, outside of an outbreak response, in health care and frontline workers in at-risk countries.
Also indexed as
Ad26.ZEBOV and MVA-BN-Filo vaccineZabdeno and Mvabea